Champagne & MDMA? Multiple Recalls After Spiked Bottles Of Moët Found
Last reviewed and updated: June 24, 2026.
Key Takeaways
| What happened | Moët champagne bottles found with MDMA deliberately introduced in distribution/retail chain; consumers could unknowingly consume MDMA + alcohol |
| Fentanyl risk | Fentanyl documented in MDMA, cocaine, counterfeit pills — active at invisible microgram doses; use fentanyl test strips to check |
| Reagent testing | Marquis turns purple-black for MDMA; Ehrlich turns purple for LSD/indoles; neither detects all adulterants — lab checking most reliable |
| Drink spiking | MDMA undetectable by sight/taste in drinks; never return to unattended drink; MDMA test strips available from harm reduction suppliers |
| Resources | DanceSafe provides drug checking at events and sells reagent testing kits; fentanyl test strips now legal in most U.S. states |
Few people popping open a bottle of the luxe brand Moët expect their champagne celebrations to turn sour. But several contaminated bottles in Europe contained the drug MDMA, making about a dozen people sick, with a link to one death.
Earlier this year, one recall (lot code LAJ7QAB6780004) of the champagne was made when a group of eight in Germany and another group of four in the Netherlands accidentally ingested liquid from tampered-with bottles of Moët and Chandon XXL Ice Imperial. One German man, Harald Georg Z (52), died after taking a big gulp of what he thought was champagne while celebrating the end of COVID restrictions.
RELATED: Microdosing MDMA: What Research Says About Doing It For Mental Health Issues
Investigators found that the bottles contained no champagne at all, instead containing pure liquid MDMA. They also found that the bottles had clearly been tampered with, having been drained of the champagne and refilled with the MDMA mixture. A different cork was then used to reseal the bottle.
It’s been reported that the affected bottles contained about 1,000 times the “normal dose” of a single MDMA pill, but recreational doses of the drug have varied widely over the past several decades. “Recreationally, pills today are often in the range of 100-250 mg,” said Dr. Sam Zand, practicing psychiatrist and Chief Medical Officer at Better U.
To put these numbers in perspective, a study in healthy subjects found that doses of 50 mg, 75 mg and 150 mg of pure MDMA resulted in a peak blood concentration of 0.106 mg/L, 0.131mg/L and 0.236 mg/L, respectively. Most of the cases of serious toxicity or fatality have involved blood levels ranging from 0.5 mg/L to 10 mg/L, that is, between five and 40 times higher than the average recreational range.
But the relationship between dose and toxicity or fatality is not clear cut.
“The pharmacokinetics of MDMA are strange in that only small increases in the dose lead to much higher, non-linear levels of MDMA concentration in the blood,” explained Dr. Bryan Quoc Le, a food scientist, food industry consultant, and author of 150 Food Science Questions Answered. Ultimately this means that even small increases in dosage may carry the risk of large increases in toxicity.
“Everyone processes drugs differently,” explained Dr. Zand. “Some could overdose on much less, and some could survive on much more. Factors to consider include age, kidney and liver function, other medications, contaminants, preexisting health conditions, overexertion, or dehydration. One thousand times [the average dose] would certainly be lethal.”
RELATED: What Does An MDMA Hangover Feel Like?
European food and drug authorities have warned against even making skin contact with any liquid suspected of contamination.
“The reason why MDMA can be life threatening even by just dipping your fingers in the bottle is because your fingers are very absorbent and accidental skin absorption is a common occurrence with methamphetamines,” said Dr. William Soliman, Ph.D. and CEO of the Accreditation Council for Medical Affairs (ACMA). “The danger of skin absorption is that the potency and dose of MDMA absorbed would not be known.”
According to Dr. Zand, MDMA overdose usually leads to hyperthermia, and overheating of the body. Others have also died from brain swelling, acute liver failure, strokes, sudden heart failure, abnormal bleeding and seizures. Hyponatremia, or abnormally low sodium in the blood, is another common cause of death in MDMA overdoses since MDMA can potentiate the ability of water to lower blood sodium levels.
The affected champagne and MDMA bottles have contained a reddish-brown liquid that looks and smells nothing like champagne. It does not sparkle, and has an anise-like smell. Anyone opening a bottle they think might be contaminated is urged to go to the police, since it has been confirmed that the tampering did not come from the manufacturer, Moët Hennessy.
A second European recall was made in June (lot code LAK5SAA6490005) when investigations uncovered another tampered-with bottle. It is not known how the MDMA ended up in the bottles, how many bottles may have been tainted and who is at risk. As yet no arrests have been made and no contaminated bottles have shown up in the United States.
Drug Supply Contamination in 2025: What the Moët Recall Tells Us About the Broader Risk
The Moët MDMA recall was a highly publicized incident, but it reflects a broader, ongoing reality: drug supply contamination — whether intentional adulteration or accidental cross-contamination — is a significant and underreported public health issue.
How drug supply contamination happens. Contamination of recreational drugs and even commercial consumer products can occur in several ways: (1) Intentional adulteration — cheaper or more potent substances added to increase weight or perceived potency (e.g., fentanyl added to heroin, MDMA added to a commercial product to increase appeal); (2) Cross-contamination in manufacturing or packaging environments (facilities that handle multiple substances); (3) Counterfeit products that mimic legitimate brands entirely. The Moët MDMA case involved spiked bottles — MDMA deliberately added to commercial champagne bottles — raising questions about supply chain integrity and the potential for unknowing consumption.
The fentanyl contamination crisis: a different scale. While the Moët recall was newsworthy, the far larger contamination crisis involves fentanyl. Illicit fentanyl has been found in cocaine, counterfeit prescription pills, MDMA, and other substances that users would not expect to contain opioids. Fentanyl is active at microgram doses — quantities invisible to the naked eye — meaning a contaminated pill or powder cannot be identified visually. This has driven the expansion of fentanyl test strip availability and harm reduction services. Fentanyl test strips, which were illegal in many states as “drug paraphernalia” until recently, have been legalized in most states as a public health measure. DanceSafe and similar organizations offer point-of-use drug checking at events.
Reagent testing and drug checking: the practical harm reduction response. Drug checking services use a combination of reagent tests, immunoassay strips, and mass spectrometry (at some venues) to identify what a substance actually contains. Reagent testing kits (Marquis, Mecke, Simon’s, Ehrlich) can confirm the presence of specific compound classes but are not definitive for purity or absence of all adulterants. For MDMA specifically: Marquis reagent turns purple-to-black for MDMA/MDA; fentanyl test strips can detect fentanyl in a dissolved sample. At-home testing provides partial assurance; laboratory testing (available through some harm reduction programs) provides much higher certainty.
Frequently Asked Questions
What happened with the Moët champagne MDMA recall?
Multiple bottles of Moët & Chandon champagne were found to contain MDMA — the drug had been deliberately introduced into the bottles, presumably after leaving the legitimate manufacturer’s control (i.e., through tampering in the distribution chain or retail environment). The recall prompted a public health warning and investigation. Consumers who unknowingly drank from affected bottles could have consumed MDMA without awareness, which is especially dangerous given potential interactions with alcohol and the unpredictability of effects without knowing the dose or that MDMA was present. The incident highlighted vulnerabilities in alcohol retail security, particularly at venues where bottles change hands repeatedly.
How can you test if a drink or drug has been spiked?
Drink spiking is difficult to detect without testing equipment. For MDMA specifically in beverages: test strips designed to detect MDMA/amphetamines in liquid can be purchased from harm reduction suppliers. Fentanyl test strips can detect fentanyl in drinks as well as drugs. For illicit drugs (pills, powders): reagent testing kits (Marquis turns purple-black for MDMA) identify drug class but not purity; fentanyl test strips detect fentanyl in a dissolved sample (dissolve a small amount in water, use the strip). Neither test is definitive for all adulterants — laboratory drug checking services provide higher certainty. DanceSafe provides drug checking resources and testing supplies.
Is fentanyl found in MDMA and other party drugs?
Yes — fentanyl contamination has been documented in MDMA, cocaine, counterfeit prescription pills (Xanax, Adderall, oxycodone fakes), and other substances. This is not universal — most MDMA does not contain fentanyl — but the risk is real and unpredictable because fentanyl is active at microgram doses invisible to the naked eye. No visual inspection can identify fentanyl contamination. The practical harm reduction response: use fentanyl test strips (dissolve a small amount of the substance in water, test with the strip). Fentanyl test strips have been legalized in most U.S. states in recent years specifically as a public health intervention. A positive test = do not use the substance.
What are the signs of MDMA in a drink?
MDMA has no distinctive color in drinks and minimal taste at typical doses when dissolved in liquid — it cannot be reliably detected by sight, taste, or smell. Effects typically begin 20–60 minutes after consumption: increased heart rate, elevated mood, heightened sensory experience, jaw tension, pupil dilation, increased sociability. In someone who does not know they consumed MDMA, these effects — particularly combined with alcohol — may be interpreted as unusual intoxication, anxiety, or feeling unwell. If you suspect a drink has been spiked, stop drinking it, tell someone you trust, and seek medical attention if symptoms are concerning. Leaving a drink unattended and then returning to it is the highest-risk scenario.
